4 big analyst cuts: Disney slashed at KeyBanc amid 'meaningful uncertainty'

Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Pfizer, Walt Disney, Delek Logistics, and Inter.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

Walt Disney downgraded at KeyBanc

KeyBanc cut Walt Disney (NYSE:DIS) to Sector Weight from Overweight, noting it prefers to step aside and wait for further catalysts amid a period of "meaningful uncertainty." It added, "Buying the dip has been a losing trade."

The firm delineated five reasons for the downgrade:

1) DIS Domestic Parks expectations appear high;

2) DIS DTC [direct-to-consumer] subscriber growth has stalled, and DIS has failed to differentiate its DTC churn vs. peers;

3) ESPN moving to streaming is materially harder than we initially thought, as our survey work shows low willingness to pay;

4) structural changes in content distribution have resulted in DIS content sales segment business that is unlikely to make money for the foreseeable future; and

5) we worry the 2024 financial setup feels a lot like 2023.

Pfizer downgraded to Neutral

Credit Suisse downgraded Pfizer (NYSE:PFE) to Neutral from Outperform and cut its price target to $40.00 from $47.00, as reported in real-time on InvestingPro.

The analyst believes Pfizer is entering "a period of uncertainty and limited pipeline catalysts," adding that it sees "greater opportunity for growth" among U.S.-based peers. Along with this, it also trimmed the company's 2023 and 2030 revenue and EPS estimates.

Shares were down fractionally in the premarket.

2 more downgrades

Citi downgraded Delek Logistics Partners (NYSE:DKL) to Sell from Neutral with a price target of $47.00.

Inter (NASDAQ:INTR) shares fell more than 3% pre-market today after JPMorgan downgraded the company to Neutral from Overweight.

Get ready to supercharge your investment strategy with our exclusive discounts.

Don't miss out on this limited-time opportunity to access cutting-edge tools, real-time market analysis, and expert insights. Join InvestingPro today and unlock your investing potential. Hurry, the Summer Sale won't last forever!